New Mexico Tech Monitor
SEE OTHER BRANDS

Exploring the science and technology news of New Mexico

New Mexico Tech Monitor: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Mexico Tech Monitor.

Press releases published on June 2, 2025

Liberation Labs is Now Liberation Bioindustries

Liberation Labs is Now Liberation Bioindustries

RICHMOND, Ind., June 02, 2025 (GLOBE NEWSWIRE) -- Liberation Labs has a new name and brand – Liberation Bioindustries. The name and brand refresh better reflect the company’s position as a global, commercial-scale, contract biomanufacturer. The company’s …

ESET Names Ryan Grant as Country Manager, US and Canada

ESET Names Ryan Grant as Country Manager, US and Canada

SAN DIEGO, June 02, 2025 (GLOBE NEWSWIRE) -- ESET, a global leader in cybersecurity, today announced that Ryan Grant has been promoted to Country Manager for US and Canada, effective June 1. Reporting to Palo Balaj, Chief Business Officer at ESET, Grant …

Actuate Therapeutics Shares Highlights from KOL Event on Positive Topline Elraglusib Phase 2 Data in First-Line Treatment of Metastatic Pancreatic Cancer

Actuate Therapeutics Shares Highlights from KOL Event on Positive Topline Elraglusib Phase 2 Data in First-Line Treatment of Metastatic Pancreatic Cancer

- Expert Insights on Clinical Relevance and Scientific Rationale - The replay of the event is available on the Investor Relations section of the Actuate website CHICAGO and FORT WORTH, Texas, June 02, 2025 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. ( …

Bondex’s Native Utility Token $BDXN Secures Listing on Binance Alpha and Futures

Bondex’s Native Utility Token $BDXN Secures Listing on Binance Alpha and Futures

LONDON, UK, June 02, 2025 (GLOBE NEWSWIRE) -- Bondex, the Web3 platform revolutionizing professional trust and credibility, has announced that its native utility token $BDXN will be listed on Binance Alpha, Binance Futures, and other leading exchanges to …

New Independent Review Paper Strengthens Therapeutic Rationale for Artelo’s FABP Inhibitor Program in Anxiety and Depression

New Independent Review Paper Strengthens Therapeutic Rationale for Artelo’s FABP Inhibitor Program in Anxiety and Depression

SOLANA BEACH, Calif., June 02, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, …

Agentuity Unveils the First Agent-Native Cloud

Agentuity Unveils the First Agent-Native Cloud

AUSTIN, Texas, June 02, 2025 (GLOBE NEWSWIRE) -- Agentuity today introduced the world’s first agent-native cloud— next-generation infrastructure meticulously engineered from first principles for autonomous AI agents. With a single command, teams can deploy …

Broadcom Announces New CloudHealth User Experience for Greater Cloud Spend Management Across Enterprise Teams

Broadcom Announces New CloudHealth User Experience for Greater Cloud Spend Management Across Enterprise Teams

PALO ALTO, Calif., June 02, 2025 (GLOBE NEWSWIRE) -- Broadcom (NASDAQ: AVGO) today announced the general availability of the newest investment made to VMware Tanzu CloudHealth, a comprehensive new user experience that delivers a suite of feature …

Full Dose-Escalation Data Show Continued High Response Rates and Favorable Safety Profile of ISB 2001, a First-in-Class BCMA × CD38 × CD3 Trispecific Antibody, for the Treatment of Relapsed/Refractory Multiple Myeloma

Full Dose-Escalation Data Show Continued High Response Rates and Favorable Safety Profile of ISB 2001, a First-in-Class BCMA × CD38 × CD3 Trispecific Antibody, for the Treatment of Relapsed/Refractory Multiple Myeloma

TRIgnite-1 study shows an overall response rate (ORR) of 74% across nine dose levels, in heavily pretreated patients with a median of six prior lines of therapy ORR is remarkably high in patients with no prior CAR-T or bispecific therapies (84%) as well as …

ASUS Wins 41 Prestigious Red Dot Design Awards for Product Design 2025, Showcasing World-Class Excellence

ASUS Wins 41 Prestigious Red Dot Design Awards for Product Design 2025, Showcasing World-Class Excellence

TORONTO, June 02, 2025 (GLOBE NEWSWIRE) -- ASUS today announced that it has been honored with 41 Red Dot Design Awards for Product Design 2025, reinforcing the company's long-standing reputation for pushing the boundaries of innovation and excellence in …

Myriad Genetics Shares New Clinical Data Demonstrating Sensitivity of Precise MRD Across Multiple Cancer Types

Myriad Genetics Shares New Clinical Data Demonstrating Sensitivity of Precise MRD Across Multiple Cancer Types

SALT LAKE CITY, June 02, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced new molecular residual disease (MRD) clinical data from the MONSTAR-SCREEN 3 study, a …

PathAI and Northwestern Medicine Announce Strategic Collaboration to Deploy the AISight® Digital Pathology Platform and Co-Develop New AI Diagnostics

PathAI and Northwestern Medicine Announce Strategic Collaboration to Deploy the AISight® Digital Pathology Platform and Co-Develop New AI Diagnostics

BOSTON and CHICAGO, June 02, 2025 (GLOBE NEWSWIRE) -- PathAI, a leading provider of AI-powered pathology solutions, and Northwestern Medicine, Chicago’s premier integrated academic health system, today announced a strategic collaboration to transform …

As BTC, XRP, and DOGE Fall, RIPPLECOIN MINING Offers a New Route to Passive Income

As BTC, XRP, and DOGE Fall, RIPPLECOIN MINING Offers a New Route to Passive Income

Los Angeles, California , June 02, 2025 (GLOBE NEWSWIRE) -- Amid the recent turbulence shaking the crypto market — with Bitcoin (BTC), Ripple (XRP), and Dogecoin (DOGE) experiencing sharp declines — investor confidence has taken a hit, and short-term …

Xilio Therapeutics Announces Pricing of $50.0 Million Public Offering

Xilio Therapeutics Announces Pricing of $50.0 Million Public Offering

WALTHAM, Mass., June 02, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced the pricing …

Ambiq Names Jeff Winzeler as Chief Financial Officer

Ambiq Names Jeff Winzeler as Chief Financial Officer

AUSTIN, Texas, June 02, 2025 (GLOBE NEWSWIRE) -- Ambiq®, a technology leader in ultra-low-power semiconductor solutions for edge AI, is pleased to announce Jeff Winzeler as Ambiq’s new Chief Financial Officer (CFO). Jeff Winzeler brings extensive CFO and …

AITX's RAD Receives RIO™ Expansion Orders from Major Client

AITX's RAD Receives RIO™ Expansion Orders from Major Client

Latest Orders Part of Ongoing National Rollout of AI-Powered Security Solutions by Leading Logistics Provider Detroit, Michigan, June 02, 2025 (GLOBE NEWSWIRE) -- Artificial Intelligence Technology Solutions, Inc. (the “Company”) (OTCPK:AITX), a global …

Dyadic Announces Leadership Change as Part of Ongoing Strategic Shift to Focus on High Demand Ancillary Proteins for Life Sciences, Nutrition, and Industrial Applications

Dyadic Announces Leadership Change as Part of Ongoing Strategic Shift to Focus on High Demand Ancillary Proteins for Life Sciences, Nutrition, and Industrial Applications

Rapid commercial validation has been achieved through key partnerships disrupting high value/high growth markets Leadership team realigned in order to enable execution of ancillary protein strategy Dyadic is well positioned to seize on geopolitical …

Catalyst Continues Growth with Hirings of Institutional Relations and Portfolio Strategist Professionals

Catalyst Continues Growth with Hirings of Institutional Relations and Portfolio Strategist Professionals

NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Catalyst Capital Advisors LLC, a leading provider of alternative and innovative investment solutions, today announced the hire of Robert Gallant, CFA, CAIA, as Executive Director of Institutional Relations, and …

Syncromune® Inc. Presents Positive Results from SYNC-T® Therapy SV-102 Phase 1 Metastatic Prostate Cancer Trial at ASCO 2025

Syncromune® Inc. Presents Positive Results from SYNC-T® Therapy SV-102 Phase 1 Metastatic Prostate Cancer Trial at ASCO 2025

Presentation highlights deep and durable responses and radiographic resolution of bone metastases in patients with advanced prostate cancer Final clinical data demonstrate an 87% overall response rate in patients with metastatic prostate cancer Results …

TELA Bio Appoints Jeffrey Blizard as President

TELA Bio Appoints Jeffrey Blizard as President

MALVERN, Pa., June 02, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (“TELA Bio”), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced the appointment of Jeffrey Blizard as President …

TruGolf Announces Listing Extension from Nasdaq

TruGolf Announces Listing Extension from Nasdaq

Salt Lake City, Utah, June 02, 2025 (GLOBE NEWSWIRE) -- TruGolf Holdings, Inc. (NASDAQ: TRUG), a leading golf technology company, today announced that the Nasdaq Hearings Panel has granted the company an extension of time to comply with Nasdaq listing …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service